More than 14 million children worldwide did not receive a single vaccine in 2024, a figure consistent with the previous year’s estimates, according to a report...
The World Health Organization (WHO) has officially recommended Gilead Sciences’ newly approved HIV pre-exposure prophylaxis (PrEP) medication, Yeztugo (lenacapavir). This endorsement follows its approval by the...
